Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Dermatologic 2

Conditions

Sarcoma, Kaposi 3Skin Neoplasms 2HIV Infections 2Sarcoma 1Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Semaxinib 3Bleomycin 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1daromun 1Tumor Necrosis Factor-alpha 1Ro 24-7429 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nelfinavir 1Molecular Diagnostic Techniques 1Mitoxantrone 1Immunotherapy 1Drug Therapy 1Daunorubicin 1Brentuximab Vedotin 1Biological Therapy 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Kaposi × Semaxinib × Clear all
NCT00003720 2012-08-23

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Pfizer

Phase 1 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT00002226 2005-06-24

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase NA Completed
30 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
30 enrolled
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡